Navigation Links
RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs

the expression of Akt2 with an siRNA, they noted a slight change in cellular glucose regulation. However, when they targeted the two isoforms of the Akt gene (Akt1 and Akt2), they noted a significant change in glucose regulation. Experiments with isoform-specific siRNA ultimately showed that Akt2, and Akt1 to a lesser extent, has an essential role in insulin-stimulated GLUT4 translocation and glucose uptake in two different cell lines, whereas Akt1 and Akt2 contribute equally to insulin-stimulated glycogen synthesis.


Functional Screening
Libraries of siRNAs targeting broad collections of genes will enable screening experiments to tie genes to cellular function. To date, libraries with more than a couple of hundred siRNAs have been limited to a few large research organizations. Recognizing the benefits of siRNA libraries, Ambion is preparing a collection of more than 1800 siRNAs targeting the known human kinases. There have been no published reports on the application of siRNA libraries in screening experiments, but screens in Drosophila and C. elegans using dsRNA libraries exemplify the opportunities.

RNAi libraries targeting more than 10,000 genes have been used in C. elegans to identify genes that regulate fat (9), life expectancy (10), and mutation control (11). A similar RNAi library for Drosophila has been used to identify the genes responsible for regulating the phosphorylation of
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8

Related biology technology :

1. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
2. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
3. An Epitope Tagging Vector for Gene Expression in Mammalian Cells
4. Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in Mammalian Cells
5. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
6. A New Lambda Vector for Mammalian Expression
7. Mammalian and Bacterial Expression in One Vector
8. Mammalian Expression Vector for Efficient Cloning of PCR Fragments
9. Mammalian Expression Vectors with Interchangeable Selectable Markers
10. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
11. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: RNAi Tool for Mammalian Gene Analysis Applications siRNAs

(Date:11/20/2009)...TOLEDO recently announced that a free webinar, &ld...At-Line Particle Characterization”, will be ...he application of in situ particle characterizatio...mize a series of roller compaction runs while vary...on forces. , (PRWEB) Nove...
(Date:11/19/2009)... Dr. Mate Hidvegi, inventor of Ave...ess release issued on November 17 by Biropharma Kf...alse and self-serving statements about its U.S. co...stated from his office in Budapest, Hungary: ,...es not apply to AveULTRA, www.aveultra.com , is...
(Date:11/19/2009)..., November 19 MONITORING FORCE Gmb... 2009 Flibanserin in the,indication treatment-rele...sease for orphan drug status designation with the ... dyskinesia is a complication of the mainstay,trea... to some of those,affected, since it may be disabl...
(Date:11/19/2009)..., November 19 AFFiRiS AG will focu...andidate at an unexpectedly early,stage of develop...er into,Phase II clinical trial early in 2010. Thi...completion of two Phase I trials with the candidat...ion on the first interim,analysis of the secondary...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...ts Senior Management Team with Recent Strategic Hi..., Puerto Rico, May 14 Triple-S,Management Corpora...ll-Rodriguez, MD, medical director at the San Jorg...or the Children,s Oncology Group and,the Dana Farb...pointed,chairman of the board of directors. He has...
...Vista Partners announced today that,it has initiat... SYI ). Ross,Silver, Director of Research of Vista...ll cap investment opportunities investors will com...rials in multi-billion dollar markets.,Additionall...could begin to,produce revenues as early as next y...
...14 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: ...t and CEO, Chris,Waddick, will present a Company o...Healthcare Conference in Monte Carlo, at 12:30 p.m...8., A live webcast of the presentation can be acc...ogen.com . An archived replay will also be availab...
Other Biology Technology:Triple-S Management Corporation Appoints New Non-Executive Chairman to Board; Adds New Director 2Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI) 2Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference 3
(Date:11/20/2009)... a respiratory disease commonly known as chronic b...e of death worldwide. 600 million people live wit...real treatment or cure, Grace Parraga of Robarts R...ario in London, Canada, is using various imaging t... , Parraga is a scientist in the Imaging Resear...
(Date:11/20/2009)...report that a class of heart medications called be... on the heart, depending on their molecular activi...irculation Research , found that beta-blockers tha... heart muscle offer the most benefit to cardiac pa...ptors can actually undermine the structure and fun...
(Date:11/19/2009)... of the last ice age, North America,s vast assembl...res as mammoths, mastodons, camels, horses, ground... slide to extinction. , And when their populatio...ge animals equaled or surpassed Africa,s wildlife-...el ecosystem emerged as broadleaved trees once kep...
Breaking Biology News(10 mins):Gaining a better picture of lung disease 2Carvedilol shown to have unique characteristics among beta blockers 2After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3When H1N1 Hits Communication From Schools to Parents is Critical 57618 1When H1N1 Hits Communication From Schools to Parents is Critical 57618 2When H1N1 Hits Communication From Schools to Parents is Critical 57618 3More People Say Medical Conditions Make it Difficult To Find a Job or Remain Employed 57615 1More People Say Medical Conditions Make it Difficult To Find a Job or Remain Employed 57615 24 Stair Lifts Announces Grand Opening of Online Store 57610 14 Stair Lifts Announces Grand Opening of Online Store 57610 2
...search Foundation (CRF) brings experts to New York...International Conference on Cell Therapy for Cardi...his emerging field, the three-day session will fea...r myocardial repair and regeneration, angiogenesis...s include: , Clinical Focus: Full-day programs...
...f the journal Emerging Infectious Diseases, Swedis...perboreal tundra, in connection with the tundra ex...cs-resistant bacteria. These findings indicate th...e, which is an alarming prospect for future health...s in northeastern Siberia, northern Alaska, and no...
...11, 2008): Nucleonics, Inc., a privately held bio...ovel RNA interference (RNAi)-based therapeutics, a... patients in a Phase 1 human safety study of its e...s (HBV) infection, NUC B1000. , NUC B1000 ( http...n expressed interfering RNA (eiRNA)-based product ...
Other Biology News:Cell Therapy for Cardiovascular Diseases 2Cell Therapy for Cardiovascular Diseases 3High degree of resistance to antibiotics in Arctic birds 2Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic 2Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic 3
... Rabbit polyclonal to Kv4.2 Immunogen Synthetic ... corresponding to amino acids 23-43 of Rat Kv4.2. ...xpected to cross-react with Human (100% identity w...n), Rabbit (100% identity with immunogen) and Ferr...
...oclonal [198C679.2.1] to Presenilin 2 Alzheimer's...he disease carry mutations in the presenilin prote...n (APP). These disease-linked mutations result in ...-beta (main component of amyloid deposits found in...
XTT (23-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) from Molecular Probes (Invitrogen)
2-Fluorine-CTP (2-F-CTP) from EPICENTRE Biotechnologies
Biology Products: